Jessica A. Kahn, MD, MPH

Interim Division Director, Adolescent and Transition Medicine

Assistant Chair, Academic Affairs and Faculty Development

Director, Office for Faculty Development

Professor, UC Department of Pediatrics

Phone 513-803-4539

Email mallory.depalma@cchmc.org

Clinical

Reproductive health; pediatric and adolescent gynecology; eating disorders; cancer prevention behaviors in adolescents; sexually transmitted infections

Research

Interdisciplinary clinical and epidemiologic studies related to prevention of cervical cancer and other diseases caused by human papillomavirus (HPV), in the United States and globally

Visit the Kahn Lab.

Jessica A Kahn, MD, MPH, is a professor of pediatrics in the Division of Adolescent and Transition Medicine at Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine in Cincinnati, Ohio. Dr. Kahn also serves as the director of the Office for Faculty Development at Cincinnati Children’s.

Dr. Kahn sees patients at Cincinnati Children's Hospital Medical Center, both at the main hospital site and at Cincinnati Children's Liberty. Her clinical interests include young women's health, pediatric and adolescent gynecology, and eating disorders. Her research interests include human papillomavirus (HPV) and Pap tests in adolescent girls, HPV vaccines, and cancer prevention behaviors in adolescents.

Dr. Kahn received her undergraduate degree in architecture from Princeton University in Princeton, New Jersey in 1986. She received her MD from Harvard Medical School in Boston, Massachusetts in 1992 and her MPH from the Harvard School of Public Health in Boston, Massachusetts in 1999. She was chief resident in pediatrics and a fellow in adolescent medicine at the Children's Hospital in Boston, Massachusetts, as well as a clinical fellow and instructor at Harvard Medical School.

Dr. Kahn's awards include the Huffman-Capraro Young Investigator Award from the North American Society for Pediatric and Adolescent Gynecology and the New Investigator Award from the Society for Adolescent Medicine. She has received research grants from the National Institutes of Health, the World Health Organization, and foundations such as the American Cancer Society. She has published numerous peer-reviewed journal articles, and is a contributing author for several medical textbooks. She serves on national and international committees and advisory groups focusing on vaccines and other adolescent health issues.

BArch: Princeton University, Princeton, NJ, 1986.

MD: Harvard Medical School, Boston, MA, 1992. 

MPH: Harvard School of Public Health, Boston, MA, 1999. 

Residency: Pediatrics, Children's Hospital, Boston, MA, 1995; Chief Resident, Pediatrics, Children's Hospital, Boston, MA, 1996. 

Fellowship: Adolescent Medicine, Children's Hospital, Boston, MA, 1999. 

Certification: American Board of Pediatrics, 1995; American Board of Pediatrics, subspecialist in Adolescent Medicine, 1999.

Mayhew A, Mullins TLK, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk Perceptions and Subsequent Sexual Behaviors after HPV Vaccination in Adolescents. Pediatrics. In press.

Vadaparampil ST, Malo TL, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, Halsey NA, Giuliano AR. Physicians’ HPV Vaccine Recommendations at Three and Five Years Post-Vaccine Licensure. Am J Prev Med. 2014 Jan;46(1):80-4.

Mullins TL, Griffioen A, Glynn S, Zimet GD, Rosenthal SL, Fortenberry JD, Kahn JA. HPV Vaccine Communication: Perspectives of 11-12 Year-Old Girls, Mothers, and Clinicians. Vaccine. 2013 Oct1;31(42):4894-901.

Kahn JA, Xu J, Kapogiannis BG, Gonin R, Rudy B, Wilson CM, Liu N, Worrell C, Squires KE. Immunogenicity and safety of the HPV -6, -11, -16, -18 Vaccine in HIV-Infected Young Women. Clin Infect Dis. 2013 Sep;57(5):735-44.

Mullins TL, Wilson CM, Rudy BJ, Sucharew H, Kahn JA. Incident Anal HPV and HPV-Related Sequelae in HIV-Infected vs. HIV-Uninfected Adolescents in the United States. Sex Transm Dis. 2013 Sep;40(9):715-20.

Kahn JA, Bernstein DI. HPV vaccination: Too soon for 2 doses? JAMA. 2013 May 1;309(17):1832-4.

Mullins TL, Rudy BJ, Wilson CM, Sucharew H, Kahn JA. Incidence of Sexually Transmitted Infections in HIV-Infected and HIV-Uninfected Adolescents in the United States. Int J STD AIDS. 2013 Feb;24(2):123-7.

Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM. Prevalence and Risk Factors for HPV in HIV-Infected Young Women Receiving Their First HPV Vaccination. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):390-9.

Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein, DI. Vaccine-Type HPV and Evidence of Herd Immunity after Vaccine Introduction. Pediatrics. 2012 Aug;130(2):e249-56.

Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Shew M, Fortenberry JD, Bernstein DI, Kahn JA. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med. 2012 Jan;166(1):82-8.